MARKET

OCEA

OCEA

Ocean Biomedical Inc.
NASDAQ
0.0636
-0.0144
-18.46%
After Hours: 0.0601 -0.0035 -5.50% 19:59 03/28 EDT
OPEN
0.0830
PREV CLOSE
0.0780
HIGH
0.0830
LOW
0.0600
VOLUME
46.32M
TURNOVER
--
52 WEEK HIGH
4.370
52 WEEK LOW
0.0511
MARKET CAP
8.94M
P/E (TTM)
-0.0655
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 1d ago
Ocean Biomedical granted notice of grant on patent right by CNIPA
TipRanks · 2d ago
OCEAN BIOMEDICAL ANNOUNCES GRANT ON PATENT RIGHT FOR BISPECIFIC ANTIBODIES TARGETING CHI3L1 AND PD1 FOR ENHANCED TUMOR CELL CYTOTOXICITY IN CHINA
Reuters · 2d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 2d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 3d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 3d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 4d ago
Weekly Report: what happened at OCEA last week (0317-0321)?
Weekly Report · 6d ago
More
About OCEA
More
Ocean Biomedical, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The Company helps to accelerates the development and commercialization of assets from research universities and medical centers. In oncology, it is engaged in developing a mono-specific and two bi-specific humanized monoclonal antibodies (mAb), product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer (NSCLC), and of glioblastoma multiforme (GBM). It offers three product candidates based on the novel target discoveries: a malaria vaccine candidate targeting either or both of PfSEA-1, and parasite antigen PfGARP, which is referred to as its ODA-570 candidate; a humanized mAb malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-611 candidate, and a small molecule malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-579 candidate.
Recently
Symbol
Price
%Change

Webull offers Ocean Biomedical Inc stock information, including NASDAQ: OCEA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCEA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCEA stock methods without spending real money on the virtual paper trading platform.